| Blood coagulation factor XIII and factor XIII deficiency A Dorgalaleh, J Rashidpanah Blood reviews 30 (6), 461-475, 2016 | 169 | 2016 |
| Effect of thyroid dysfunctions on blood cell count and red blood cell indice A Dorgalaleh, M Mahmoodi, B Varmaghani, OS Kia, S Alizadeh, ... Iranian journal of pediatric hematology and oncology 3 (2), 73, 2013 | 141 | 2013 |
| Standardization of prothrombin time/international normalized ratio (PT/INR) A Dorgalaleh, EJ Favaloro, M Bahraini, F Rad International journal of laboratory hematology 43 (1), 21-28, 2021 | 97 | 2021 |
| Anemia and thrombocytopenia in acute and chronic renal failure A Dorgalaleh, M Mahmudi, S Tabibian, ZK Khatib, GH Tamaddon, ... International journal of hematology-oncology and stem cell research 7 (4), 34, 2013 | 92 | 2013 |
| Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency M Naderi, A Dorgalaleh, S Alizadeh, S Tabibian, S Hosseini, ... International journal of hematology 100, 443-449, 2014 | 91 | 2014 |
| Factor XIII deficiency in Iran: a comprehensive review of the literature A Dorgalaleh, M Naderi, MS Hosseini, S Alizadeh, S Hosseini, S Tabibian, ... Seminars in thrombosis and hemostasis 41 (03), 323-329, 2015 | 90 | 2015 |
| A comprehensive overview of coagulation factor V and congenital factor V deficiency S Tabibian, Y Shiravand, M Shams, M Safa, MS Gholami, F Heydari, ... Seminars in thrombosis and hemostasis 45 (05), 523-543, 2019 | 82 | 2019 |
| Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency A Dorgalaleh, M Naderi, M Shamsizadeh Annals of hematology 95, 451-455, 2016 | 74 | 2016 |
| Bleeding and bleeding risk in COVID-19 A Dorgalaleh Seminars in thrombosis and hemostasis 46 (07), 815-818, 2020 | 71 | 2020 |
| Guidelines for laboratory diagnosis of factor XIII deficiency A Dorgalaleh, S Tabibian, S Hosseini, M Shamsizadeh Blood coagulation & fibrinolysis 27 (4), 361-364, 2016 | 56 | 2016 |
| Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran A Dorgalaleh, SER Alavi, S Tabibian, S Soori, E Moradi, T Bamedi, ... Hematology 22 (4), 224-230, 2017 | 52 | 2017 |
| Hemophilia in Iran A Dorgalaleh, G Dadashizadeh, T Bamedi Hematology 21 (5), 300-310, 2016 | 51 | 2016 |
| Current understanding in diagnosis and management of factor XIII deficiency M Naderi, A Dorgalaleh, S Tabibian, S Alizadeh, P Eshghi, G Solaimani Iranian journal of pediatric hematology and oncology 3 (4), 164, 2013 | 48 | 2013 |
| Diagnosis of factor XIII deficiency A Dorgalaleh, S Tabibian, MS Hosseini, Y Farshi, F Roshanzamir, ... Hematology 21 (7), 430-439, 2016 | 45 | 2016 |
| A prospective study of tubular dysfunction in pediatric patients with beta thalassemia major receiving deferasirox M Naderi, S Sadeghi-Bojd, AK Valeshabad, A Jahantigh, S Alizadeh, ... Pediatric hematology and oncology 30 (8), 748-754, 2013 | 42 | 2013 |
| Patients with congenital bleeding disorders appear to be less severely affected by SARS-CoV-2: is inherited hypocoagulability overcoming acquired hypercoagulability of … A Dorgalaleh, A Dabbagh, S Tabibian, MR Baghaeipour, M Jazebi, ... Seminars in thrombosis and hemostasis 46 (07), 853-855, 2020 | 38 | 2020 |
| Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders M Naderi, S Tabibian, S Alizadeh, S Hosseini, F Zaker, T Bamedi, ... Acta haematologica 133 (2), 148-154, 2015 | 38 | 2015 |
| Intracranial hemorrhage in congenital bleeding disorders S Tabibian, H Motlagh, M Naderi, A Dorgalaleh Blood Coagulation & Fibrinolysis 29 (1), 1-11, 2018 | 37 | 2018 |
| Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders—prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency SER Alavi, M Jalalvand, V Assadollahi, S Tabibian, A Dorgalaleh Seminars in thrombosis and hemostasis 44 (03), 267-275, 2018 | 36 | 2018 |
| Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. M Naderi, A Dorgalaleh, S Alizadeh, Z Kashani Khatib, S Tabibian, ... Haemophilia 20 (1), 2014 | 35 | 2014 |
